← Russell 3000 cross-section

OSCR Oscar Health, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-07, not restated
Financials

Scale

Market cap
$9.5bn
Revenue TTM
$30m
Net income TTM
$551m
Free cash flow
$4.4bn
Composite score
66.9
Sector rank
#741

Valuation

P / E
17.3
EV / EBITDA
2.2
EV / sales
48.1
FCF yield
45.88%
Earnings yield vs 10-yr
1.04pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
1,861.9%
EBITDA margin
2,224.4%
ROE
26.8%
ROIC
Revenue growth
44.0%

Insider activity, last 90 days

Net open-market
$-104.91m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We regularly review our total revenue, medical loss ratio (“MLR”), selling, general, and administrative expense ratio (“SG&A expense ratio”), earnings from operations, and net income attributable to Oscar Health, Inc. to evaluate our business, measure our performance, identify trends in our business, prepare financial projections, and make strategic decisions. Total Revenue Total revenue includes premium revenue (net of risk adjustment transfers), investment income, and other revenues. We believe total revenue is an important metric to assess the growth of our business, as well as the earnings potential of our investment portfolio. Net Income (Loss) Attributable to Oscar Health, Inc. …Oscar Health, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-07

Read the full passage →